Catalog #CD5
CJC-1295 (With DAC)
5 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$75.00
Technical Research Description
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analog featuring a maleimidoproprionic acid linker that enables covalent binding to serum albumin. This modification extends the half-life to approximately 6-8 days, allowing for sustained elevation of growth hormone and IGF-1 levels.
Simplified Explanation
This version of CJC-1295 includes a special attachment that lets it bind to proteins in blood, dramatically extending how long it stays active. One dose can stimulate growth hormone release for nearly a week. Scientists study its prolonged effects on growth hormone pathways.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for CJC-1295 (With DAC) 5 MG — sourced from our research articles.
research
Sermorelin Acetate: A GHRH Analog for GH Studies
Sermorelin acetate is a GHRH analog used to probe pituitary GH release in preclinical models. Here's how researchers design studie…
Sep 9, 2026
research
CJC-1295 (Without DAC): What It Enables in GH Research
A research-first look at CJC-1295 (Without DAC): receptor pharmacology, pulse biology, assay design, and how it differs from DAC v…
Sep 1, 2026
research
Tirzepatide dual receptor mechanism, decoded
A research-first look at how tirzepatide engages GIP and GLP-1 receptors, shaping signaling bias, crosstalk, and metabolic readout…
Aug 26, 2026
research
Tesamorelin: what it reveals about GH pulse biology
Tesamorelin is a GHRH analog used in growth-axis research. Here's what the literature suggests about pulsatile GH signaling and st…
Aug 26, 2026
research
Ipamorelin in GH Signaling: What the Data Suggests
Ipamorelin is a ghrelin-receptor agonist used in GH-axis research. Here's what preclinical literature suggests about signaling, se…
Aug 13, 2026
research
CJC-1295 (With DAC): designing longer GH signals
A research-focused look at CJC-1295 (With DAC), how DAC extends exposure, and where it fits among GHRH analogs and secretagogues.
Aug 8, 2026